Stock Events

Stock Events

Search...

Revitalist Lifestyle and Wellness

C$0.02

0

+C$0+0% Tuesday 20:00

Statistics

Day High

0

Day Low

0

52W High

0.02

52W Low

0

Volume

0

Avg. Volume

0

Mkt Cap

1.59M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

2MayExpected

Q2 2021

Q3 2021

Q1 2022

-0.06

0.27

0.61

0.94

Expected EPS

N/A

Actual EPS

-0.06

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CALM.CN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Compass Pathways

COMPASS Pathways focuses on psilocybin therapy for mental health, directly competing with Revitalist's psychedelic-assisted therapies.

Mind Medicine develops psychedelic therapies, including for mental health issues, competing in the same emerging sector as Revitalist.

GH Research is involved in the development of therapeutic solutions using psychedelics, making it a competitor in the psychedelic medicine space.

ATAI Life Sciences N.V.

ATAI Life Sciences is a biotech company focusing on psychedelic and non-psychedelic compounds for mental health, competing with Revitalist's approach to wellness.

Cybin Inc. works on psychedelic drug development for mental health conditions, positioning it as a competitor in the psychedelic treatment market.

About

Revitalist Lifestyle and Wellness Ltd. operates medical clinics. The company offers ketamine-enhanced psychotherapy, psychedelic-enhanced psychotherapy, medicative infusion therapy, vitamin infusions, transcranial magnetic stimulation, psychotherapy, and other medications focusing on mental health and acupuncture. As of March 31, 2022, it operated 9 clinics in the United States. Revitalist Lifestyle and Wellness Ltd. was incorporated in 2018 and is headquartered in Vancouver, Canada.

Show more...

CEO

Ms. Kathryn Walker APRN, CRNA

Country

CA

ISIN

CA76151T1030

WKN

000A3C36K

Listings